Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

about

B cells as biomarkers: predicting immune checkpoint therapy adverse events.Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.SIRT6 haploinsufficiency induces BRAF melanoma cell resistance to MAPK inhibitors via IGF signalling

P2860

Q47225274-3AAA1E7D-DA30-41A5-A88E-417EB983A8E7 Q47227422-04A89A0A-E9D4-4674-857A-6DAB254615B9 Q57010854-B1D16535-CA0B-45F5-9DA1-70700F8CAF58

P2860

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Item

http://www.wikidata.org/entity/Q41701119

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

@en

type

Item

label

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

@en

prefLabel

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

@en

P1476

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

@en

P2093

Ahmad Jalili

http://www.w3.org/2001/XMLSchema#string

Arjun Raj

http://www.w3.org/2001/XMLSchema#string

Brian J Czerniecki

http://www.w3.org/2001/XMLSchema#string

Brian J Gavin

http://www.w3.org/2001/XMLSchema#string

Christine Hafner

http://www.w3.org/2001/XMLSchema#string

Christine Wagner

http://www.w3.org/2001/XMLSchema#string

Courtney Ellingsworth

http://www.w3.org/2001/XMLSchema#string

Courtney Hudgens

http://www.w3.org/2001/XMLSchema#string

Denitsa Hristova

http://www.w3.org/2001/XMLSchema#string

Dennie Tompers Frederick

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of melanomas by targeted elimination of a minor subset of tumor cells

A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

A tumorigenic subpopulation with stem cell properties in melanomas

A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

Final version of 2009 AJCC melanoma staging and classification

lumi: a pipeline for processing Illumina microarray

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

P2888

s41467-017-00452-4

P304

607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-017-00452-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rajasekharan Somasundaram

Lawrence W. Wu

Michela Perego

Helmut Schaider

Mizuho Fukunaga-Kalabis

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28928360

http://www.w3.org/2001/XMLSchema#string

P932

5605714

http://www.w3.org/2001/XMLSchema#string

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

about

P2860

P2860

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932